DE69326292T2 - Retinsäuren und Tocopherol enthaltende Zusammensetzungen - Google Patents

Retinsäuren und Tocopherol enthaltende Zusammensetzungen

Info

Publication number
DE69326292T2
DE69326292T2 DE69326292T DE69326292T DE69326292T2 DE 69326292 T2 DE69326292 T2 DE 69326292T2 DE 69326292 T DE69326292 T DE 69326292T DE 69326292 T DE69326292 T DE 69326292T DE 69326292 T2 DE69326292 T2 DE 69326292T2
Authority
DE
Germany
Prior art keywords
tocopherol
compositions containing
retinoic acids
containing retinoic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69326292T
Other languages
English (en)
Other versions
DE69326292D1 (de
Inventor
Nagy Christa Fiedler
Timothy Warington Quick
Stanley Seymour Shapiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69326292D1 publication Critical patent/DE69326292D1/de
Application granted granted Critical
Publication of DE69326292T2 publication Critical patent/DE69326292T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69326292T 1992-07-10 1993-06-25 Retinsäuren und Tocopherol enthaltende Zusammensetzungen Expired - Fee Related DE69326292T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/911,606 US5252604A (en) 1992-07-10 1992-07-10 Compositions of retinoic acids and tocopherol for prevention of dermatitis

Publications (2)

Publication Number Publication Date
DE69326292D1 DE69326292D1 (de) 1999-10-14
DE69326292T2 true DE69326292T2 (de) 2000-05-11

Family

ID=25430554

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326292T Expired - Fee Related DE69326292T2 (de) 1992-07-10 1993-06-25 Retinsäuren und Tocopherol enthaltende Zusammensetzungen

Country Status (14)

Country Link
US (1) US5252604A (de)
EP (1) EP0578077B1 (de)
JP (1) JPH0751490B2 (de)
CN (1) CN1051704C (de)
AT (1) ATE184192T1 (de)
AU (1) AU666949B2 (de)
CA (1) CA2098550A1 (de)
DE (1) DE69326292T2 (de)
DK (1) DK0578077T3 (de)
ES (1) ES2137209T3 (de)
GR (1) GR3031900T3 (de)
NZ (1) NZ248069A (de)
RU (1) RU2111745C1 (de)
ZA (1) ZA934778B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5431913A (en) * 1992-01-24 1995-07-11 Phillips; Eva J. Skin cleansing and exfoliant composition and method of treating skin
WO1995003028A1 (en) * 1993-07-23 1995-02-02 Morris Herstein Cosmetic, skin-renewal stimulating composition with long-term irritation control
JP2742333B2 (ja) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるビタミンｅトコフェリル誘導体の使用
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
FR2738743B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation de l'acide ascorbique comme actif pour le traitement de la seborrhee dans une composition cosmetique et/ou dermatologique
US5738856A (en) * 1995-11-03 1998-04-14 Ocular Research Of Boston, Inc. Skin care preparation and method
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US5855893A (en) * 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
DE19820392A1 (de) * 1998-05-07 1999-11-11 Beiersdorf Ag Wirkstoffkombinationen enthaltende Hautpflegemittel
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
CN1374953A (zh) 1999-09-16 2002-10-16 田边制药株式会社 含氮的6－员芳香环化合物
DE60104206T2 (de) * 2000-09-22 2005-09-22 Galephar M/F Halbfeste arzneizubereitung enthaltend isotretinoin
JP4759182B2 (ja) * 2001-08-03 2011-08-31 花王株式会社 水溶性ショウキョウエキス
JP2005501094A (ja) * 2001-08-21 2005-01-13 ガリレオ ファーマシューティカルズ， インコーポレイティド トコフェロール富化組成物および炎症性症状の回復
WO2003043570A2 (en) * 2001-11-15 2003-05-30 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
DE10162727A1 (de) * 2001-12-20 2003-07-10 Henkel Kgaa Neue Alkalische Protease aus Bacillus gibsonii (DSM 14391) und Wasch-und Reinigungsmittel enthaltend diese neue Alkalische Protease
DE10233740A1 (de) * 2002-07-24 2004-02-05 Basf Ag Retinoid-haltige Zubereitungen
DE602004015808D1 (de) * 2003-09-15 2008-09-25 Unilever Nv Verfahren zur glättung von haaren mit zusammensetzungen mit einer alpha-hydroxy-säure und einem reduktionsmittel
WO2005048929A2 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
CN1942178A (zh) * 2004-02-19 2007-04-04 奥克塞尔公司 用于治疗皮肤疾病的局部制剂
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US7399493B2 (en) * 2004-07-16 2008-07-15 Wille John J Anti-irritant botanicals
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006034570A1 (en) 2004-09-28 2006-04-06 Chemaphor Inc. Compositions and methods for promoting weight gain and feed conversion
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
AU2008316225B2 (en) * 2007-10-26 2014-06-19 Avivagen Inc. Compositions and methods for enhancing immune response
EP2376198B1 (de) 2008-12-22 2018-03-28 Johnson & Johnson Consumer Holdings France Zusammensetzung enthaltend ein Retinoid und Verfahren zur Behandlung von Hauterkrankungen
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
US10123970B2 (en) * 2009-05-20 2018-11-13 Sun Pharmaceutical Industries Limited Topical retinoid solutions
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
EP2729148A4 (de) 2011-07-06 2015-04-22 Parkinson S Inst Zusammensetzungen und verfahren zur behandlung von symptomen bei patienten mit morbus parkinson
US9078925B2 (en) 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
EP2915557B1 (de) * 2012-11-02 2018-05-09 Cosmed Pharmaceutical Co., Ltd. Retinsäure-mikronadel
US20140179722A1 (en) 2012-12-14 2014-06-26 The Procter & Gamble Company Antiperspirant and Deodorant Compositions
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
WO2014144265A1 (en) * 2013-03-15 2014-09-18 The Procter & Gamble Company A noninvasive method for measuring oxidative stress and oxidative damage from skin
US20150184111A1 (en) * 2013-12-26 2015-07-02 Jose A. Rodriguez Perfume and use thereof
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
EP3267875A4 (de) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Eingabe- und unterstützungssystem für heftiges verlangen
EP3368009A4 (de) 2015-10-30 2018-09-05 Patagonia Pharmaceuticals, LLC Isotretinoinformulierungen sowie verwendungen und verfahren dafür
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
JPS61207332A (ja) * 1985-03-12 1986-09-13 Nisshin Kagaku Kk 皮膚疾患治療剤
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
US4900550A (en) * 1987-08-19 1990-02-13 Amy Allene Cosmetiques, Inc. Skin care cosmetic regime

Also Published As

Publication number Publication date
EP0578077A3 (en) 1994-06-29
EP0578077B1 (de) 1999-09-08
EP0578077A2 (de) 1994-01-12
CN1051704C (zh) 2000-04-26
ES2137209T3 (es) 1999-12-16
CN1086709A (zh) 1994-05-18
CA2098550A1 (en) 1994-01-11
DK0578077T3 (da) 2000-01-31
AU666949B2 (en) 1996-02-29
JPH0751490B2 (ja) 1995-06-05
RU2111745C1 (ru) 1998-05-27
NZ248069A (en) 1994-12-22
GR3031900T3 (en) 2000-02-29
DE69326292D1 (de) 1999-10-14
JPH0687741A (ja) 1994-03-29
AU4156493A (en) 1994-01-13
ZA934778B (en) 1994-01-10
US5252604A (en) 1993-10-12
ATE184192T1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
DE69326292D1 (de) Retinsäuren und Tocopherol enthaltende Zusammensetzungen
ATE209032T1 (de) Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität
ATE306919T1 (de) Verwendung zur topischen anwendung von tocotrienol auf die haut und haare
ES2058517T3 (es) Composicion cosmetica.
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
NO931390D0 (no) Vandig gelbaerer for retinoider
AU674142B2 (en) Use of cosmetic composition
ATE147265T1 (de) Verwendung von retinoiden zur umkehr glucocorticoid-induzierter hautatrophie
ATE369850T1 (de) Topische anwendung von vitamin e ester
ES2193218T3 (es) Combinacion de sustancias activas contra el acne y los comedones inflamados.
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
DK0599114T3 (da) Vitamin D3-analoge
DE68925609T2 (de) Esterderivate von mit Alkohol modifizierten Siloxanen und kosmetische Zusammensetzungen, die diese Derivate enthalten
NO902104L (no) Kosmetisk blanding.
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
ATE54413T1 (de) In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.
JPS54132242A (en) Cosmetics
ITMI921866A1 (it) Uso dell'oxatomide come agente antitosse
PT779075E (pt) Aplicacao de 3-alfa-hidroxi-5-alfa-androsta-16-eno como medicamento

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee